Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer

Esophageal cancer is the eighth most common malignancy and the sixth leading cause of cancer-related deaths worldwide. Chemotherapy based on platinum drugs, 5-fluorouracil, adriamycin, paclitaxel, gemcitabine, and vinorelbine, as well as targeted treatment and immunotherapy with immune checkpoint in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ling Wei, Jujie Sun, Nasha Zhang, Yue Shen, Teng Wang, Zengjun Li, Ming Yang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/120ec580cf31457798702ef13132b2c7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:120ec580cf31457798702ef13132b2c7
record_format dspace
spelling oai:doaj.org-article:120ec580cf31457798702ef13132b2c72021-11-22T06:09:58ZNovel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer2296-634X10.3389/fcell.2021.764313https://doaj.org/article/120ec580cf31457798702ef13132b2c72021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcell.2021.764313/fullhttps://doaj.org/toc/2296-634XEsophageal cancer is the eighth most common malignancy and the sixth leading cause of cancer-related deaths worldwide. Chemotherapy based on platinum drugs, 5-fluorouracil, adriamycin, paclitaxel, gemcitabine, and vinorelbine, as well as targeted treatment and immunotherapy with immune checkpoint inhibitors improved the prognosis in a portion of patients with advanced esophageal cancer. Unfortunately, a number of esophageal cancer patients develop drug resistance, resulting in poor outcomes. Multiple mechanisms contributing to drug resistance of esophageal cancer have been reported. Notably, non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), have been identified to play crucial roles in modulating esophageal cancer drug resistance. In the present review, we highlight the underlying mechanisms how miRNAs, lncRNAs, and circRNAs impact the drug resistance of esophageal cancer. Several miRNAs, lncRNAs, and circRNAs may have potential clinical implications as novel biomarkers and therapeutic targets for esophageal cancer.Ling WeiJujie SunNasha ZhangYue ShenTeng WangZengjun LiMing YangFrontiers Media S.A.articleesophageal cancerdrug resistancemicroRNAlong non-coding RNAcircular RNABiology (General)QH301-705.5ENFrontiers in Cell and Developmental Biology, Vol 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic esophageal cancer
drug resistance
microRNA
long non-coding RNA
circular RNA
Biology (General)
QH301-705.5
spellingShingle esophageal cancer
drug resistance
microRNA
long non-coding RNA
circular RNA
Biology (General)
QH301-705.5
Ling Wei
Jujie Sun
Nasha Zhang
Yue Shen
Teng Wang
Zengjun Li
Ming Yang
Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer
description Esophageal cancer is the eighth most common malignancy and the sixth leading cause of cancer-related deaths worldwide. Chemotherapy based on platinum drugs, 5-fluorouracil, adriamycin, paclitaxel, gemcitabine, and vinorelbine, as well as targeted treatment and immunotherapy with immune checkpoint inhibitors improved the prognosis in a portion of patients with advanced esophageal cancer. Unfortunately, a number of esophageal cancer patients develop drug resistance, resulting in poor outcomes. Multiple mechanisms contributing to drug resistance of esophageal cancer have been reported. Notably, non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), have been identified to play crucial roles in modulating esophageal cancer drug resistance. In the present review, we highlight the underlying mechanisms how miRNAs, lncRNAs, and circRNAs impact the drug resistance of esophageal cancer. Several miRNAs, lncRNAs, and circRNAs may have potential clinical implications as novel biomarkers and therapeutic targets for esophageal cancer.
format article
author Ling Wei
Jujie Sun
Nasha Zhang
Yue Shen
Teng Wang
Zengjun Li
Ming Yang
author_facet Ling Wei
Jujie Sun
Nasha Zhang
Yue Shen
Teng Wang
Zengjun Li
Ming Yang
author_sort Ling Wei
title Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer
title_short Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer
title_full Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer
title_fullStr Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer
title_full_unstemmed Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer
title_sort novel implications of micrornas, long non-coding rnas and circular rnas in drug resistance of esophageal cancer
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/120ec580cf31457798702ef13132b2c7
work_keys_str_mv AT lingwei novelimplicationsofmicrornaslongnoncodingrnasandcircularrnasindrugresistanceofesophagealcancer
AT jujiesun novelimplicationsofmicrornaslongnoncodingrnasandcircularrnasindrugresistanceofesophagealcancer
AT nashazhang novelimplicationsofmicrornaslongnoncodingrnasandcircularrnasindrugresistanceofesophagealcancer
AT yueshen novelimplicationsofmicrornaslongnoncodingrnasandcircularrnasindrugresistanceofesophagealcancer
AT tengwang novelimplicationsofmicrornaslongnoncodingrnasandcircularrnasindrugresistanceofesophagealcancer
AT zengjunli novelimplicationsofmicrornaslongnoncodingrnasandcircularrnasindrugresistanceofesophagealcancer
AT mingyang novelimplicationsofmicrornaslongnoncodingrnasandcircularrnasindrugresistanceofesophagealcancer
_version_ 1718418085926404096